Urapidil 98.0%(HPLC)
98.0%(HPLC)
Properties
| Vapour pressure | 0.0±1.5 mmHg at 25℃ |
| Assay Purity | >98%(HPLC) |
| Refractive index | 1.622 |
| B pt. | 549℃ at 760 mmHg |
| M pt. | 159℃ |
| Density | 1.26 g/cm3 |
Safety Information
| Hazard Statement(s) | H302 |
| Precautionary Statement | P501-P270-P264-P301 + P312 + P330 |
| Symbol |
|
| Signal word | Warning |
| Flash point | 285.8℃ |
| Storage Temp. | Store at room temperature |
| Storage Class | 6.1 |
| Packaging | Glass Bottle |
| UN Number | 2927 |
Description
Recommended products
Trans-Urocanic Acid 98.0%(HPLC)
Application
Urapidil is an 1 adrenoreceptor antagonist and a 5-HT1A receptor agonist.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Urapidil is a sympatholytic antihypertensive drug. It acts as an 1-adrenoceptor antagonist and as an 5-HT1A receptor agonist Although an initial report suggested that urapidil was also an 2-adrenoceptor agonist this was not substantiated in later studies that demonstrated it was devoid of agonist actions in the dog saphenous vein and the guinea-pig ileum. Unlike some other 1-adrenoceptor antagonists urapidil does not elicit reflex tachycardia and this may be related to its weak 1-adrenoceptor antagonist activity as well as its effect on cardiac vagal drive. Urapidil is currently not approved by the U.S. Food and Drug Administration but it is available in Europe.
Documents
| SDS |
| COA |
| Specification |
| Bulk quote order form |